This summary was created by AI, based on 5 opinions in the last 12 months.
Sangoma Technologies Corp. (STC-T) has experienced significant volatility in the past year, with a pronounced spike, subsequent drop, and a recovery phase prompted by a new CEO. The shift towards better integration of products and a focus on margins have garnered positive feedback from experts, who highlight the impressive management changes and the potential for organic growth. Analysts emphasize that the company's performance metrics, particularly EBITDA margins and margin expansion, indicate an upward trajectory. Given its low price-to-earnings ratio relative to peers, many believe the stock is currently undervalued and poised for further re-rating as operational performance improves.
Sangoma Technologies Corp. is a Canadian stock, trading under the symbol STC-T on the Toronto Stock Exchange (STC-CT). It is usually referred to as TSX:STC or STC-T
In the last year, 9 stock analysts published opinions about STC-T. 3 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Sangoma Technologies Corp..
Sangoma Technologies Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Sangoma Technologies Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
9 stock analysts on Stockchase covered Sangoma Technologies Corp. In the last year. It is a trending stock that is worth watching.
On 2025-04-02, Sangoma Technologies Corp. (STC-T) stock closed at a price of $6.48.
The chart shows a massive spike up, massive drop, and now recovery in the past year. They likely paid too much for a company in 2022 and were trading at a high PE. He had added shares in 2023-4 after a new CEO started bundling products, focus on margins and integrated companies. Has been doing a good job. He expects them to return to growth this year at 10% organically and 18% EBITDA margins. Looks cheap, half the PE of peers.